Safety and Efficacy of Dara-VTD Induction and Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients Presenting with Renal Failure - a Tertiary Centre UK Experience on Behalf of the UK-MRA
Adrian Maraj(King's College Hospital), Kirsty Cuthill, Victoria Potter(King's College Hospital NHS Foundation Trust), Neeraj Kohli(St Thomas' Hospital), Arief Gunawan(St Thomas' Hospital), Piers Patten, Madson Correia de Farias, Matthew Streetly(King's College - North Carolina), John R. Jones(King's College Hospital), Paul Donohoe(King's College Hospital), Sajitha Sachchithanantham(The Royal Free Hospital), Stella Bowcock(King's College Hospital), Katharine Bailey(King's College Hospital NHS Foundation Trust), Asma Batool, Majid Kazmi, Kate Bramham(King's College - North Carolina), María Cuadrado(University College London), Reuben Benjamin(King's College London)
Cited by 0
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421